Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives

Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives

According to the World Cancer Report, cancer rates have been increased by 50% with 15 million new cases in the year 2020. Hepatocellular carcinoma (HCC) is the only one of the most common tumors to cause a huge increase in mortality with a survival rate between 40% and 70% at 5 years, due to the hig...

Full description

Bibliographic Details
Main Authors: Annalisa Chianese, Biagio Santella, Annalisa Ambrosino, Debora Stelitano, Luca Rinaldi, Massimiliano Galdiero, Carla Zannella, Gianluigi Franci
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
oncolytic virus
combination treatment
cancer
epigenetic
tumor resistance
HCC
Online Access:https://www.mdpi.com/2072-6694/13/11/2761

Internet

https://www.mdpi.com/2072-6694/13/11/2761

Similar Items